The protective effect of L-glutamine against acute Cantharidin-induced Cardiotoxicity in the mice
BMC Pharmacology and Toxicology volume 21, Article number: 71 (2020)
Cantharidin (CTD) is a compound which have the potential to be exploited as an antitumor drug, and it has been demonstrated antitumor effects in a variety of cancers. However, the use is limited due to its severe toxicity. It has reported that it can induce fatal cardiac arrhythmias. Fortunately, we found that L-glutamine can alleviate cardiac toxicity caused by cantharidin in mice.
To investigate the protective effect of L-glutamine, we used a high dose of cantharidin in mice to create a model of cardiotoxicity. In the experimental mice, glutamine was given orally half an hour before they were administrated with cantharidin. The mice of control group were intraperitoneally injected with DMSO solution. The general state of all mice, cardiac mass index, electrocardiogram change and biological markers were determined. Hematoxylin-eosin staining (HE staining) of heart tissue was carried out in each group to reflect the protective effect of glutamine. To investigate the mechanisms underlying the injury and cardio-protection, multiple oxidative stress indexes were determined and succinate dehydrogenase activity was evaluated.
The results showed that L-glutamine (Gln) pretreatment reduced weight loss and mortality. It also decreased the biological markers (p < 0.05), improved electrocardiogram and histological changes that CTD induced cardiotoxicity in mice. Subsequently, the group pretreated with L-glutamine before CTD treatment increases in MDA but decreases in SOD and GSH, in comparison to the group treated with CTD alone. Besides, succinate dehydrogenase activity also was improved when L-glutamine was administrated before cantharidin compared to cantharidin.
This study provided evidence that L-glutamine could protect cardiac cells against the acute cantharidin-induced cardiotoxicity and the protective mechanism of glutamine may be related to the myocardial cell membrane or the tricarboxylic acid cycle in the mitochondria.
Cantharidin (CTD) is extracted from blister beetle as one of the terpenoid compound used in treating cancers . From latest previous studies, it found that cantharidin showed potential anticancer activities in wide variety of tumor, such as lung cancer , gastric cancer , pancreatic cancer [4,5,6], epidermoid carcinoma . In terms of the mechanism, cantharidin can induce the apoptosis of cancer cells by suppressing the activity of protein phosphatase 2A [4, 8]. Meanwhile, the side effects of cantharidin also should be understood in more detail and attenuated before it can be better and safely used for the management of cancers.
It has many reports suggested that cantharidin can cause toxicity in many organs, such as hepatotoxicity , nephrotoxicity , and urinary system damage . Most importantly, Rabkin SW has reported that cantharidin shows cardiotoxic properties because it can induce fatal cardiac arrhythmias. Therefore, as a model of cardiac arrhythmias, it was a tool to research the curative effect of antiarrhythmic drugs . Accordingly, we have created a mouse poisoning model to screen for drugs that reduce the toxicity of cantharidin. Fortunately, we found that glutamine could relieve its side effects, to some extent.
In mammalian heart cells, L-glutamine (Gln) is one of the major intracellular free amino acids . Gln plays an essential part for the function of biologic organs and tissues, such as heart . It can also be used as a source of energy. Mao Y et al. found that Gln could improve cardiac function against acute myocardial infarction and regulate the metabolism of endothelial nitric oxide in the heart [15, 16]. It was also reported that L-glutamine has a protective effect based on the myocardial antioxidant defense system, where oxidative stress causes proteins , DNA  and lipids  damage, subsequently cardiac damage.
The efficacy of oral glutamine was established in doxorubicin-induced cardiotoxicity . Hence, we wonder whether glutamine can also protect against CTD-induced heart damage in mice. In our study, we investigated the mechanism of Gln by testing the value of SOD and MDA related to the antioxidant defense system and by evaluating the activity of succinate dehydrogenase in the TCA cycle. Therefore, we hypothesized that disruption of the myocardial mitochondria is the cause of damage produced by cantharidin on the heart, and that L-glutamines’ antioxidant properties may be the reason for its ability, to a certain extent, to protect myocardial mitochondria.
Drugs and chemicals
Cantharidin (purity ≥98%, detail molecular formula in Fig. 1a and b) was purchased from Chengdu Must Bio-Technology CO., Ltd. L-glutamine was purchased from Beijing Topbio Science & Technology CO., Ltd. (purity ≥98%, detail molecular formula in Fig. 1c and d).
Animals and treatment
All balb/c mice were females aged 6 weeks, weighed 18 ± 2 g, and were obtained from SPF (Beijing) Biotechnology Co., Ltd. All of the mice were raised at a temperature of 25 ± 2 °C and a humidity of 60 ± 1% under a 12-h dark/light cycle with standard food and clean water in an animal facility. Mice were euthanized by cervical dislocation after completion of the experiment.
To clearly state the cardiac toxicity of cantharidin and the regulation of glutamine, we assessed the low dose (2 mg/kg) and high does (3 mg/kg) combined with L-glutamine. First 20 mice were assigned to the 4 groups randomly: (1) Control group: mice were intraperitoneally injected with a 200 μL DMSO solution. (2) CTD group: mice were treated with equal volumes of 2 mg/kg cantharidin-DMSO solution. (3) Gln 1 + 2 mg/kg CTD group: mice were pre-treated with 1 g/kg glutamine orally before being injected with 2 mg/kg cantharidin-DMSO solution. (4) Gln 2 + 2 mg/kg CTD group: mice were pre-treated with 2 g/kg glutamine orally before being injected with 2 mg/kg cantharidin-DMSO solution. All Intervention is given every 2 days in four group in 5 days.
Then, we assess the survivorship curve for 3 mg/kg cantharidin in which there were 36 mice were randomly assigned to 3 groups: (1) CTD group: mice were treated with equal volumes of 3 mg/kg cantharidin-DMSO solution. (2) Gln 1 + CTD group: mice were pre-treated with 1 g/kg glutamine orally before being injected with 3 mg/kg cantharidin-DMSO solution. (3) Gln 2 + CTD group: mice were pre-treated with 2 g/kg glutamine orally before being injected with 3 mg/kg cantharidin-DMSO solution. All Intervention is given every 2 days in three group in 5 days.
In order to assess the detail cardiotoxicity for cantharidin and the protection of L-glutamine, 24 mice were assigned to the 4 groups randomly: (1) Ctrl group: mice were intraperitoneally injected with a 200 μL DMSO solution. (2) CTD group: mice were treated with equal volumes of 3 mg/kg cantharidin-DMSO solution. (3) Gln 1 + CTD group: mice were pre-treated with 1 g/kg glutamine orally before being injected with 3 mg/kg cantharidin-DMSO solution. (4) Gln 2 + CTD group: mice were pre-treated with 2 g/kg glutamine orally before being injected with 3 mg/kg cantharidin-DMSO solution. The administration was only one time and 4 h after administration we would collect the biological tissues from mice in order to test Biological markers of cardiotoxicity, Histopathological studies, enzymatic biomarkers of oxidative stress and Succinate dehydrogenase staining.
Twenty mice were assigned to the 4 groups randomly: (1) Control group: mice were intraperitoneally injected with a 200 μL DMSO solution. (2) CTD group: mice were treated with equal volumes of 3 mg/kg cantharidin-DMSO solution. (3) Gln 1 + CTD group: mice were pre-treated with 1 g/kg glutamine before being injected with 3 mg/kg cantharidin-DMSO solution. (4) Gln 2 + CTD group: mice were pre-treated with 2 g/kg glutamine before being injected with 3 mg/kg cantharidin-DMSO solution. After 3 h of administration, 45 mg/kg sodium pentobarbital was injected intraperitoneally to anesthetize mice. After the anesthesia, mice were fixed to the mouse plate with tape by supine position. Spray the mouse hair with an alcohol spray can and disinfect it. Use a curved scissors to shave the hair off the mouse’s chest (or use a shaver). Connect the leads of the electrocardiograph (Cardimax FX-7202) to the limbs and the heart, as required. Connect the power and print the ECG drawing after the heart rate is basically stable. Scan ECG drawings and analyze changes in each band.
Biological markers of cardiotoxicity
After electrocardiographic assessment, blood was collected from retro-orbital plexus under mild anesthesia. Mice were sacrificed and the hearts were collected immediately. The fresh heart was divided into three parts: one part of the heart was fixed in the 4% formalin for histopathological examination; the other parts of the heart were immediately embedded with a frozen biopsy agent; and the remaining parts were collected for biochemical analysis.
Serum was collected through centrifugation at 3500 rpm (10 min, 4 °C). Serum levels of creatine kinase (CK), creatine kinase-MB isoenzyme (CK-MB), lactate dehydrogenase (LDH) enzymes, and aspartate aminotransferase (AST) were tested by automated chemistry analyzer (CX4 Pro, Beckman Coulter, USA) using reagent kits.
The heart was sliced into small pieces and preserved for 24 h in 4% formalin. Specimens were sliced into sections 4 mm thick. The specimen was made transparent by xylene, and subsequently mounted by neutral resin, then stained by hematoxyline and eosin.
Effect of oxidative stress on enzymatic biomarkers
The one part of heart tissues was homogenized in chilled homogenizing buffer by a tissue homogenizer and centrifuged at 3500 rpm.(10 min, 4 °C). The SOD activity was estimated in the serum and myocardium using the Marklund & Marklund method . GSH content was estimated by the Subramaniam method. MDA content in supernatant of the mice was tested by Slater and Sawyer method . Protein concentrations were tested by the BAC protein detection kit. (Beijing Solarbio Science & Technology Co., Ltd.)
The second portion of isolated heart was embedded with a frozen biopsy agent and immediately placed in a − 80 °C environment. The frozen sections were made of Leica frozen microtome and stained using a Succinate dehydrogenase staining kit (Beijing Solarbio Science & Technology Co., Ltd.)
The data form was the mean ± S.D. which was analyzed by IBM SPSS statistical software package (version 20). Statistical comparisons were made using Student’s t-test and one-way analysis of variance (ANOVA). p < 0.05 was considered as statistically significant.
The general state of mice
First, weight change showed that all of three groups administrated with 2 mg/kg cantharidin loss their weight significantly compared with control group. Meanwhile, the groups 1 g/kg glutamine combined with 2 mg/kg cantharidin and 2 g/kg glutamine combined with 2 mg/kg cantharidin showed a good protection effect, especially using 2 g/kg glutamine which had a significant effect compared with CTD group (Fig. 2). We also assessed the survivorship curve in high dose cantharidin (3 mg/kg cantharidin) combined with glutamine, it showed that the single using of 3 mg/kg cantharidin would lead to quicker death compared with cantharidin combined with glutamine (Fig. 3).
Cardiac mass index
Then, we assessed the acute toxicity of CTD (3 mg/kg) which was used alone or combined with glutamine. The mouse and its heart were weighed, the ratio of heart weight to body mass (mg/g) was calculated. The groups of Gln 1 + CTD and Gln 2 + CTD showed that the increase in heart weight was lower than CTD group. The ratio of heart weight/body mass (mg/g) in the group of Gln 2 + CTD was lower than the group of CTD (Fig. 4).
From the ECG of different groups, we found the group administrated with 3 mg/kg cantharidin that the ST segment was higher than that of control group. Meanwhile, the ST-segment elevation of two groups, respectively administrated with 1 g/kg and 2 g/kg glutamine before giving cantharidin, were less than the group administrated with 3 mg/kg cantharidin. The myocardial damage caused by cantharidin alleviated by glutamine (Fig. 5) .
Effect on cardiac biomarkers
It is well known that cardiac enzymes are significant diagnostic biomarkers of myocardial damage. In the present study, CTD increases the levels of enzymes such as CK (p < 0.01), CK-MB (p < 0.01), AST (p < 0.01), and LDH (p < 0.01) significantly compared with the control group. While, pretreatment with Gln decreased the indices of enzymes which were increased by CTD (Fig. 6).
Histopathology of mice hearts
Figure 7 showed histopathological change by HE staining for heart. The histopathological change in controlled mice showed absence of myocardial inflammation indicating normal architecture of the heart. Compared with the control group, the CTD 3 mg·kg-1 group mice showed inflamations, myocardial interstitial hyperemia (Fig. 7f). It confirms that CTD has caused damage in the heart. Pretreatment of L-glutamine reduced myocardial inflammation compared with single use of CTD (Fig. 7i and l). In conclusion, CTD caused pathological changes, while L-glutamine protected the heart tissue to some degree.
Effect on oxidative stress parameters
Compared with the ctrl group, the value of SOD and GSH of the CTD group increased significantly (p < 0.05). Moreover, MDA reduced significantly (p < 0.05) (Table 1 and Fig. 8). It means that the use of CTD resulted in oxidative stress in the early stage of heart damage in mice. However, with enough volume of glutamine pretreatment in mice, the concentration of SOD, GSH, and MDA has less influence compared to the mice treated with CTD alone.
Succinate dehydrogenase staining (SDH) in frozen sections
Figure 9 depicts the SDH staining results of the following groups of mice: the control group mice, CTD treated mice, mice that were pretreated with 1 g/kg Gln, and mice that were pretreated with 2 g/kg Gln. As we can see in Fig. 9, the heart tissue of CTD treated mice showed large areas of superficial dyeing; the blue stained color was lighter compared with the control group mice. While, the group of glutamine pretreated mice showed a deeper staining compared with the CTD group mice. This suggests that the activity of succinate dehydrogenase in CTD treated mice was lower compared with the control group and the activity of succinate dehydrogenase was recovered after administration of glutamine.
In this study, we showed the cardiac toxicity induced by cantharidin, and showed that glutamine is protective. For this reason, we have made a brief explanation of the discovery in terms of biochemical indicators and H&E staining.
From the mentioned results, the parameter of biomarker enzymes (CK, CK-MB, AST and LDH) in plasma increased in CTD group compared to the control mice. These biomarker enzymes reflect a non-specific aberration for the functional and structural completeness of myocardial membranes as a response to CTD damage. Histopathological studies revealed an inflammatory infiltrate in the outer ventricular membrane in CTD treated mice. There was a greater space between the cardiomyocytes, as compared to the control mice. It is consistent with the characteristics of cantharidin damaging tissues and cells reported by Fillmore K. et . The disruption of the membrane structure of cardiac myocytes was further confirmed in our experiment.
Meanwhile, prior prescription of L-glutamine could decrease the release of cytosolic enzymes into circulation. L-glutamine pretreated animals showed no apparent abnormalities of histopathology compared with the control group mice, that demonstrated the protective effect on the heart cells; Yan et al. also reported that L-glutamine seems to have a protective effect after myocardial damage .
To further investigate the potential mechanism of the toxicity caused by CTD in the mice heart. We have determined the enzymatic biomarkers of oxidative stress, such as SOD, GSH and MDA, and stained succinate dehydrogenase, which can be used to manifest the active of mitochondrial in cardiac myocyte. As a vital defense enzyme, SOD can catalyze the dismutation of superoxide radicals. Glutathione (GSH) is able to prevent the damage of important cellular components by reactive oxygen species . As the oxidative degradation product, the level of MDA is an indicator of lipid peroxidation origin from cell-membrane lipids . In the present study, we found that the mice treated with cantharidin resulted in a transient elevation of SOD and GSH. Furthermore, the amount of MDA was significantly different from the mice in the control group. There are two hypotheses to explain the phenomenon.1) In the previous report, CTD can efficiently inhibit the activity of mammalian protein phosphatase 2A (PP2A) . Tsung-I Chen et al. found that ROS generation increases PP2A activation, while its activation can be inhibited by the cantharidin and SOD . It suggested that cantharidin may inhibit PP2A activation by increasing SOD level. 2) In the general state, the tissue would increase the SOD and GSH level to protect cells from ROS damage in a short time, but ultimately reduced SOD and GSH level because of the continued consumption [29, 30]. Considered that we took blood in an early time, it is possible. In both cases, it implies ROS response was induced in the early stages of damage in CTD-treated mice heart.
In addition, succinate dehydrogenase is the only enzyme which participates in both the electron transport chain and the citric acid cycle . Chouchani showed selective accumulation of intermediate succinate in citric acid cycle is a common metabolic characteristic of ischaemia which is responsible for mitochondrial ROS production during reperfusion in a range of organs and tissues . In our experiments, succinic dehydrogenase staining was lighter in the CTD group, meaning its activity decreased. In the earlier study of cantharidin, it was reported that cantharidin possibly affects the cell membrane, for example via some subcellular particles . According to our data, CTD really destroys cells or mitochondria, which increases oxidative stress products and reduces mitochondrial marker enzymes. We speculate that the destruction of the cell membrane or mitochondrial membrane structure, induced by CTD, prompts the change of various makers.
As principal energy source, Glutamine was used to formate mitochondrial ATP in oxidative metabolism of mitochondria which drive the contraction of heart [33, 34]. It has been reported that sudden elimination of Gln could lead to a sharp decline of mitochondrial respiration . As an enzyme complex, succinate dehydrogenase exists in the inner mitochondrial membrane of heart cells. The activity of succinate dehydrogenase in the groups of pretreated with high dose glutamine was almost the same as that of the control group mice. The protective effect may be due to the mechanism that the catalysis of glutamine into glutamate provides the urgent needed substrate, utilized as energy production in the citric acid cycle, to counteract membrane disintegration induced by cantharidin in the myocardium referred to Dumaswala’ study . From our results, we found that 2 mg·ml− 1 L-glutamine pretreated mice showed no significant difference with the control animals on SOD, GSH and MDA parameters. It reminded us that glutamine protective role in heart tissue may be also related to the ROS response. The accumulation of succinate will be re-oxidized rapidly by succinate dehydrogenase after damage which will lead to generation of excess ROS by reverse electron transport in mitochondrial complex I. As to glutamine, it may protect several protein complexes in the mitochondria.
Cantharidin showed certain anticancer activities in a wide variety of tumors in vivo and vitro, while it can cause toxicity in many organs especially in the heart. In our animal experiment, as one of the major intracellular free amino acids, L-glutamine could alleviate cardiac toxicity that caused by cantharidin in a spectrum of experiments, including ECG test, myocardial enzyme, histopathology and so on.
Availability of data and materials
The relevant data to work have been included in the paper. However, the supplementary data may be shared on request to the main contributing authors on request.
- ECG test:
Creatine kinase-MB isoenzyme
Lactate dehydrogenase enzymes
Kim JA, Kim Y, Kwon BM, Han DC. The natural compound cantharidin induces cancer cell death through inhibition of heat shock protein 70 (HSP70) and Bcl-2-associated athanogene domain 3 (BAG3) expression by blocking heat shock factor 1 (HSF1) binding to promoters. J Biol Chem. 2013;288:28713–26.
Hsia TC, Yu CC, Hsu SC, Tang NY, Lu HF, Yu CS, Wu SH, Lin JG, Chung JG. cDNA microarray analysis of the effect of cantharidin on DNA damage, cell cycle and apoptosis-associated gene expression in NCI-H460 human lung cancer cells in vitro. Mol Med Rep. 2015;12:1030–42.
Zhang C, Chen Z, Zhou X, Xu W, Wang G, Tang X, Luo L, Tu J, Zhu Y, Hu W, et al. Cantharidin induces G2/M phase arrest and apoptosis in human gastric cancer SGC-7901 and BGC-823 cells. Oncol Lett. 2014;8:2721–6.
Li W, Xie L, Chen Z, Zhu Y, Sun Y, Miao Y, Xu Z, Han X. Cantharidin, a potent and selective PP2A inhibitor, induces an oxidative stress-independent growth inhibition of pancreatic cancer cells through G2/M cell-cycle arrest and apoptosis. Cancer Sci. 2010;101:1226–33.
Shen M, Wu MY, Chen LP, Zhi Q, Gong FR, Chen K, Li DM, Wu Y, Tao M, Li W. Cantharidin represses invasion of pancreatic cancer cells through accelerated degradation of MMP2 mRNA. Sci Rep. 2015;5:11836.
Wu MY, Xie X, Xu ZK, Xie L, Chen Z, Shou LM, Gong FR, Xie YF, Li W, Tao M. PP2A inhibitors suppress migration and growth of PANC-1 pancreatic cancer cells through inhibition on the Wnt/beta-catenin pathway by phosphorylation and degradation of beta-catenin. Oncol Rep. 2014;32:513–22.
Li CC, Yu FS, Fan MJ, Chen YY, Lien JC, Chou YC, Lu HF, Tang NY, Peng SF, Huang WW, Chung JG. Anticancer effects of cantharidin in A431 human skin cancer (Epidermoid carcinoma) cells in vitro and in vivo. Environ Toxicol. 2017;32:723–38.
Hill TA, Stewart SG, Sauer B, Gilbert J, Ackland SP, Sakoff JA, McCluskey A. Heterocyclic substituted cantharidin and norcantharidin analogues--synthesis, protein phosphatase (1 and 2A) inhibition, and anti-cancer activity. Bioorg Med Chem Lett. 2007;17:3392–7.
Wu W, Su M, Li T, Wu K, Wu X, Tang Z. Cantharidin-induced liver injuries in mice and the protective effect of vitamin C supplementation. Int Immunopharmacol. 2015;28:182–7.
Massicot F, Dutertre-Catella H, Pham-Huy C, Liu XH, Duc HT, Warnet JM. In vitro assessment of renal toxicity and inflammatory events of two protein phosphatase inhibitors cantharidin and nor-cantharidin. Basic Clin Pharmacol Toxicol. 2005;96:26–32.
Deng L, Tang S. Norcantharidin analogues: a patent review (2006 - 2010). Expert Opin Ther Pat. 2011;21:1743–53.
Rabkin SW, Friesen JM, Ferris JA, Fung HY. A model of cardiac arrhythmias and sudden death: cantharidin-induced toxic cardiomyopathy. J Pharmacol Exp Ther. 1979;210:43–50.
Roth E. Nonnutritive effects of glutamine. J Nutr. 2008;138:2025s–31s.
El-Sheikh NM, Khalil FA. L-arginine and L-glutamine as immunonutrients and modulating agents for oxidative stress and toxicity induced by sodium nitrite in rats. Food Chem Toxicol. 2011;49:758–62.
Mao Y, Wang SQ, Mao XB, Zeng QT, Li YS. Intestinal barrier function in patients with acute myocardial infarction and the therapeutic effect of glutamine. Int J Cardiol. 2011;146:432–3.
Murphy C, Newsholme P. Glutamine as a possible precursor of L-arginine and thus nitric oxide synthesis in murine macrophages. Biochem Soc Trans. 1997;25:404s.
Mihm MJ, Yu F, Weinstein DM, Reiser PJ, Bauer JA. Intracellular distribution of peroxynitrite during doxorubicin cardiomyopathy: evidence for selective impairment of myofibrillar creatine kinase. Br J Pharmacol. 2002;135:581–8.
L'Ecuyer T, Sanjeev S, Thomas R, Novak R, Das L, Campbell W, Heide RV. DNA damage is an early event in doxorubicin-induced cardiac myocyte death. Am J Phys Heart Circ Phys. 2006;291:H1273–80.
Myers CE, McGuire WP, Liss RH, Ifrim I, Grotzinger K, Young RC. Adriamycin: the role of lipid peroxidation in cardiac toxicity and tumor response. Science. 1977;197:165–7.
Todorova VK, Kaufmann Y, Hennings L, Klimberg VS. Oral glutamine protects against acute doxorubicin-induced cardiotoxicity of tumor-bearing rats. J Nutr. 2010;140:44–8.
Marklund S, Marklund G. Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem. 1974;47:469–74.
Slater TF, Sawyer BC. The stimulatory effects of carbon tetrachloride on peroxidative reactions in rat liver fractions in vitro. Inhibitory effects of free-radical scavengers and other agents. Biochem J. 1971;123:823–8.
Bagatell FK, Dugan K, Wilgram GF. Structural and biochemical changes in tissues isolated from the cantharidin-poisoned rat with special emphasis upon hepatic subcellular particles. Toxicol Appl Pharmacol. 1969;15:249–61.
Yan H, Zhang Y, Lv SJ, Wang L, Liang GP, Wan QX, Peng X. Effects of glutamine treatment on myocardial damage and cardiac function in rats after severe burn injury. Int J Clin Exp Pathol. 2012;5:651–9.
Pompella A, Corti A. Editorial: the changing faces of glutathione, a cellular protagonist. Front Pharmacol. 2015;6:98.
Alessio HM, Goldfarb AH. Lipid peroxidation and scavenger enzymes during exercise: adaptive response to training. J Appl Physiol. 1988;64:1333–6.
Wang G, Dong J, Deng L. Overview of Cantharidin and its analogues. Curr Med Chem. 2018;25:2034–44.
Chen TI, Chiu HW, Pan YC, Hsu ST, Lin JH, Yang KT. Intermittent hypoxia-induced protein phosphatase 2A activation reduces PC12 cell proliferation and differentiation. J Biomed Sci. 2014;21:46.
Tong C, Liu Y, Zhang Y, Cong P, Shi X, Liu Y, Shi Hongxu Jin L, Hou M. Shock waves increase pulmonary vascular leakage, inflammation, oxidative stress, and apoptosis in a mouse model. Exp Biol Med (Maywood). 2018;243:934–44.
Parmeggiani B, Grings M, da Rosa-Junior NT, Britto R, Wajner M, Leipnitz G. Bezafibrate prevents glycine-induced increase of antioxidant enzyme activities in rat striatum. Mol Neurobiol. 2019;56:29–38.
Oyedotun KS, Lemire BD. The quaternary structure of the Saccharomyces cerevisiae succinate dehydrogenase. Homology modeling, cofactor docking, and molecular dynamics simulation studies. J Biol Chem. 2004;279:9424–31.
Chouchani ET, Pell VR, Gaude E, Aksentijevic D, Sundier SY, Robb EL, Logan A, Nadtochiy SM, Ord ENJ, Smith AC, et al. Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS. Nature. 2014;515:431–5.
Kumar SH, Anandan R. Biochemical studies on the cardioprotective effect of glutamine on tissue antioxidant defense system in isoprenaline-induced myocardial infarction in rats. J Clin Biochem Nutr. 2007;40:49–55.
Piva TJ, McEvoy-Bowe E. Oxidation of glutamine in HeLa cells: role and control of truncated TCA cycles in tumour mitochondria. J Cell Biochem. 1998;68:213–25.
Darmaun D. Role of glutamine depletion in severe illness. Diabetes Nutr Metab. 2000;13:25–30.
Dumaswala UJ, Rugg N, Greenwalt TJ. Studies in red blood cell preservation: 9. The role of glutamine in red cell preservation. Vox Sang. 1994;67:255–9.
We thank all those who provided excellent technical support and assistance during the study.
The design of the study, collection, analysis, and interpretation of data was supported by the grant Basic scientific research operating expenses of the institute of basic theory for traditional Chinese medicine, No: YZ-1873.
Ethics approval and consent to participate
All experimental procedures were reviewed and approved by the Beijing University of Chinese Medicine Animal Care and Use Committee and were in accordance with the institutional guidelines for the Care and Use of Laboratory Animals (Project No: 1040053310002/002).
Consent for publication
There are no conflicts of interest to declare.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Shao, H., Dong, L., Feng, Y. et al. The protective effect of L-glutamine against acute Cantharidin-induced Cardiotoxicity in the mice. BMC Pharmacol Toxicol 21, 71 (2020). https://doi.org/10.1186/s40360-020-00449-8
- Poisonousness reduces